Covid-19 roundup: Tri­al of Trump's fa­vorite Covid-19 drug nixed on ear­ly death risk; Is An­tho­ny Fau­ci on thin ice with the pres­i­dent?

A study in­volv­ing one of Pres­i­dent Trump’s fa­vorite Covid-19 drugs had to be halt­ed ear­ly af­ter re­searchers de­ter­mined that the high dose of the treat­ment was linked to a high­er risk of death.

Brazil­ian re­searchers had planned to en­list 440 pa­tients to test chloro­quine — close­ly con­nect­ed to hy­drox­y­chloro­quine — in in­fect­ed pa­tients. But re­searchers quick­ly spot­ted the safe­ty is­sue. The ab­stract of their pub­lished study con­clud­ed:

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.